ONE-WAYOngoing theme · still written in the latest filings

Development and Commercialization of SP-04 PledOx in Japan and Asia

A theme aimed at commercializing SP-04 PledOx by advancing next-phase clinical trials and trials in Chinese subjects in Japan and other Asian markets, while exploring the potential to expand its indications to taxane-induced peripheral neuropathy.

Companies1How many companies write about this.

Threads2One company can carry more than one thread here.

PeriodFY2017 →Still being written about.

Directionhelps2 helps · 0 hurts · 0 flat